|
07 Jul 2008 |
Early findings show promise as AS1411 AML study proceeds to higher-dose stage
|
|
03 Jul 2008 |
VAVELTA(R) Phase II data presented at FACE
|
|
02 Jul 2008 |
MicroIslet Provides Safety and Efficacy Data Update
|
|
02 Jul 2008 |
Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
|
|
02 Jul 2008 |
Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
|
|
30 Jun 2008 |
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
|
|
30 Jun 2008 |
Teva & ANP Announce That Atl/Tv1102, a Novel Drug for The Treatment Of Relapsing Remitting Multiple Sclerosis (Rrms), Demonstrated Significant Reduction In Disease Activity
|
|
25 Jun 2008 |
FDA approves Quark IND for DGFi, an siRNA therapeutic based on Silence Therapeutics’ Unique Proprietary Chemistry
|
|
25 Jun 2008 |
Osiris Therapeutics Announces $2 Million Milestone Payment for Clinical Progress of a Stem Cell Therapy for Type 1 Diabetes
|
|
22 Jun 2008 |
Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
|
|
19 Jun 2008 |
Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
|
|
18 Jun 2008 |
AVONTEC announces results of a multiple dose clinical phase I study with its drug candidate AVT-02 UE ointment after topical treatment in male healthy volunteers
|
|
17 Jun 2008 |
Aastrom to Initiate Phase II Clinical Trial Using Cardiac Repair Cells Derived From Patient's Own Bone Marrow for Treatment of Severe Chronic Heart Failure
|
|
16 Jun 2008 |
Opexa Therapeutics Presents Monocyte-Derived Islet Cell Research at the International Society for Stem Cell Research Annual Meeting
|
|
15 Jun 2008 |
AMT prepares for submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
|
|
12 Jun 2008 |
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
|
|
12 Jun 2008 |
Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
|
|
10 Jun 2008 |
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
|
|
09 Jun 2008 |
Gentium Announces Update from Data Safety Monitoring Board Review of the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
|
|
08 Jun 2008 |
Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
|
|
04 Jun 2008 |
Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
|
|
04 Jun 2008 |
Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
|
|
03 Jun 2008 |
Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
|
|
03 Jun 2008 |
EMEA provides Guidance on Phase III Design and Approval Requirements
|
|
03 Jun 2008 |
Anti-TGF-beta Antisense AP 12009 shows very good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma
|
